FDA Approves Apellis EMPAVELI (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older
Proven efficacy across all three key markers of disease—68% reduction in proteinuria,…
Strength Building: How Strength Training Supplements Help You Build Muscle Mass and Keep Growing Stronger – CrazyBulk
New York City, NY, July 28, 2025 (GLOBE NEWSWIRE) -- Build muscle…
CodeMonkey Expands Offerings with New High School Coding Courses, Now Providing a Complete K12 Computer Science Curriculum
SAN FRANCISCO, July 28, 2025 (GLOBE NEWSWIRE) -- CodeMonkey, a leading provider…
ASM announces completion of share buyback program
Almere, The NetherlandsJuly 28, 2025, 5:45 p.m. CET ASM International N.V. (Euronext…
Testosterone Booster for Muscle Gain: Men Opt for OTC Supplement Form Natural Testosterone Replacement Therapy (TRT) Treatment in 2025
New York City, NY, July 27, 2025 (GLOBE NEWSWIRE) -- A recent…
Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025
July 25, 2025 16:15 ET | Source: Portage Biotech Inc. DOVER, Del.,…
Benefits Reimagined Unveils AI-Powered ACA Application on SAP BTP
Revolutionizing Compliance with Advanced Technology July 26, 2025 10:00 ET | Source:…
Free Psychic Reading Online | Free Psychic Chat 2025s Most Trusted Spiritual Guidance Platform, by The Psychic Experts
New York City, NY, July 26, 2025 (GLOBE NEWSWIRE) -- New York…
Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop
– Phase 1a clinical data in healthy participants presented for both ABI-5366…
Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis onAugust 5, 2025
SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi”…